WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer
about
Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasionNF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivationNormal growth and development in mice over-expressing the CCN family member WISP3Update on inflammatory breast cancerInhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells.Inflammatory breast cancer: New factors contribute to disease etiology: A reviewTranscriptome markers of viral persistence in naturally-infected andes virus (bunyaviridae) seropositive long-tailed pygmy rice ratsMesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes.Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.RhoC expression and head and neck cancer metastasis.Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signalingSilencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signalingGenetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast.Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and MoroccoInflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancerAssociation of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestrationThe CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signalingThe current understanding of the molecular determinants of inflammatory breast cancer metastasis.WISP3 is highly expressed in a subset of colorectal carcinomas with a better prognosis.Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer.Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis.Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesisExpression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse.Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoCOverexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells.RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4.Pomegranate fruit extract impairs invasion and motility in human breast cancer.Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathwayHow do I treat inflammatory breast cancer?Farnesyl transferase inhibitors.Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients.The emerging role of CCN6 in breast cancer invasion.Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management.
P2860
Q22000757-3ED2D90D-1512-4745-8F89-B9467360FC0EQ24653076-4C42CC42-A601-488F-AF7B-BB132AA59B32Q24656664-B7835D7D-832C-4E6B-9BE3-7C470A98E4B1Q24797853-16731E2B-C018-4A99-824C-1581E15732BFQ25257817-1052DED6-5925-4254-896D-2FEA5C594072Q27027856-5B686ADD-F66F-4309-AAA8-1F0D2D9A6590Q27310102-78878AD6-8187-44F8-912E-A1E3BB9149F6Q33680909-CF22B0CE-35A8-4077-8178-0468DB0117D6Q33826097-2218D0F4-0BA6-41C8-828A-65AEB0FBAACFQ33870504-3E8A3115-B8B8-4669-BF92-5CF426BD3684Q33921489-B1F85B22-CB57-40A3-90AE-31F9A01B98C9Q34147662-DD1FC644-6FFD-4916-8C47-19F81E39268DQ34501883-CAF3D779-970F-4D30-BA8B-A8B502B43720Q34698214-80786D9B-F16D-4C87-A9D9-94871C1428ECQ34918207-2DAE7553-FF56-47ED-B9D2-FF90DD907E20Q34918360-463D8E59-2DA5-4FF7-B677-3A93F40FF00CQ35642344-906350FF-FDD3-457C-8261-23F258EA1A04Q35662191-FCE60099-AC89-4776-8064-2EF0CEF7D812Q35829855-2DCC20CA-8E56-4356-8D58-A8CD2B06765AQ35970905-45E53965-3AF2-433F-A4C7-B6E8D88CDBE0Q36461733-CFD19DE0-9703-4D6A-AF93-3A332023E8B1Q36473625-D89FCA22-5E54-4192-BC02-87C8B9006B66Q36512260-E10F5CD6-E905-4537-8956-ED5ABC0C91FCQ36514752-E1AAEA46-27CC-4B55-99B6-9EBC5BEC2BFBQ36599823-1FA950A8-52E9-42D9-97E8-D8D0B91F050AQ36611440-56D65638-F9D0-415C-BFD5-EF2F81502236Q36919258-FE03E6F4-F0CB-41F4-9314-3599736065C8Q36958447-90C13DA8-8F5C-410B-A2E2-1EBDFE62AD28Q37216665-43964F67-06C7-4EF1-A086-C65F0FB3DC94Q37473906-12A5AB4A-871A-450A-917D-E4E300E8DD59Q39085721-414EC0D3-C15C-4205-95A5-A486A7EDA2DAQ39691131-82E5D3FC-DFF4-4D05-8AE5-0951EFA4C464Q39789722-D4E76C86-B60B-491D-90E1-3252430B61BEQ40221236-47F56FEA-6DD3-443C-BF93-9179D6DB211CQ41967598-BF1C09A5-850E-46D0-9154-85E5DCDE4169Q44586994-E98E2DBB-66BE-42A5-8E15-5DD2FFF1CB28Q46456381-BB707AA6-BB75-4555-B81B-926A90B62A04Q46511043-EB07A1D0-5B75-476D-96FD-F080A16981C7Q47112126-C066B48F-6B9C-4E22-851A-4646F9266EB0Q54283392-4825C01F-A2E8-4F84-A18C-27EBB64CE4A8
P2860
WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@ast
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@en
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@nl
type
label
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@ast
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@en
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@nl
prefLabel
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@ast
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@en
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@nl
P2093
P2860
P356
P1476
WISP3 and RhoC guanosine triph ...... of inflammatory breast cancer
@en
P2093
Celina G Kleer
Gary Gallagher
Quintin Pan
Sofia D Merajver
Yanhong Zhang
Zhi-Fen Wu
P2860
P2888
P304
P356
10.1186/BCR755
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1042336774